1887

Journal of General Virology header logo

Volume 74, Issue 3

Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes Free

Abstract

A monoclonal antibody (MAb 2c) specific for glycoprotein B of herpes simplex virus (HSV) mediated clearance of the virus from the infected mucous membranes. Young adult C57BL/6J mice were inoculated intravaginally with HSV type 1 and injected intraperitoneally either 24 and 72 h or 65 and 265 h post-inoculation with a polyclonal immune serum or the MAb 2c, both adjusted to the same neutralizing capacity. Immunization with the polyclonal immune serum did not alter the duration of virus shedding from the genital mucous membranes although a lethal outcome of infection was clearly prevented. Immunization with the MAb, however, resulted in a rapid clearance of the virus from the genital tract thus completely inhibiting genital inflammation and lethality. The same effects were achieved in mice depleted of CD4 T cells although peripheral virus replication continued longer in these mice. In mice depleted of both CD4 and CD8 T cells the polyclonal immune serum was no longer able to protect against lethality, and virus replication in the mucous membranes persisted until the mice died. In contrast, after treatment with the MAb peripheral infection was quickly eliminated and all mice survived. These findings indicate that clearance of the virus from the primary site of replication can be mediated by humoral immunity. The relevance of this observation for vaccination against HSV is discussed.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1993
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-3-379
1993-03-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/3/JV0740030379.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-3-379&mimeType=html&fmt=ahah

References

  1. Balachandran N., Bacchetti S., Rawls W. E. 1982; Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infection and Immunity 37:1132–1137
     [Google Scholar]
  2. Banks T. A., Rouse B. T. 1992; Herpesviruses - immune escape artists?. Clinical Infectious Diseases 14:933–941
     [Google Scholar]
  3. Baron S., Worthington M. G., Williams J., Gaines J. W. 1976; Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature, London 261:505–506
     [Google Scholar]
  4. Blacklaws B. A., Nash A. A. 1990; Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice. Journal of General Virology 71:863–871
     [Google Scholar]
  5. Bonneau R. H., Jennings S. R. 1989; Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. Journal of Virology 63:1480–1484
     [Google Scholar]
  6. Bonneau R. H., Jennings S. R. 1990; Herpes simplex virus-specific cytolytic T lymphocytes restricted to a normally low responder H-2 allele are protective in vivo. Virology 174:599–604
     [Google Scholar]
  7. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. 1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature, London 312:548–551
     [Google Scholar]
  8. Dix R. D., Pereira L., Baringer J. R. 1981; Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infection and Immunity 34:192–199
     [Google Scholar]
  9. Eis A. M., Schneweis K. E. 1986; Pathogenesis of genital herpes simplex virus infection in mice. IV. Quantitative aspects of viral latency. Medical Microbiology and Immunology 175:281–292
     [Google Scholar]
  10. Eis-Hübinger A. M., Mohr K., Schneweis K. E. 1991; Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection. Intervirology 32:351–360
     [Google Scholar]
  11. Eis-Hübinger A. M., Friedrich A., Schneweis K. E. 1992; Herpes simplex virus-specific hybridoma cells cannot be persistently infected with this virus. Intervirology 34:13–22
     [Google Scholar]
  12. Erlich K. S., Dix R. D., Mills J. 1987; Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin. Antimicrobial Agents and Chemotherapy 31:1006–1009
     [Google Scholar]
  13. Fridlaender R. P., Oh J. O., Minasi P., Ohashi Y. 1987; Protective effect of passive immunization on herpetic retinitis of newborn rabbits. Current Eye Research 6:161–166
     [Google Scholar]
  14. Inoue Y., Oh J. O., Minasi P. 1991; Protective effect of antiglycoprotein D antibody on herpetic chorioretinitis in newborn rabbits. Current Eye Research 10:159–165
     [Google Scholar]
  15. Kahlon J., Whitley R. J. 1988; Antibody response of the newborn after herpes simplex virus infection. Journal of Infectious Diseases 158:925–933
     [Google Scholar]
  16. Kapoor A. K., Nash A. A., Wildy P. 1982a; Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity. Journal of General Virology 61:127–131
     [Google Scholar]
  17. Kapoor A. K., Nash A. A., Wildy P., Phelan J., McLean C. S., Field H. J. 1982b; Pathogenesis of herpes simplex virus in congenitally athymie mice: the relative roles of cell-mediated and humoral immunity. Journal of General Virology 60:225–233
     [Google Scholar]
  18. Kohl S. 1991; Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections. Reviews of Infectious Diseases 13:108–114
     [Google Scholar]
  19. Lausch R. N., Oakes J. E., Metcalf J. F., Scimeca J. M., Smith L. A., Robertson S. M. 1989; Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. Current Eye Research 8:499–506
     [Google Scholar]
  20. McDermott M. R., Brais L. J., Evelegh M. J. 1990; Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. Journal of General Virology 71:1497–1504
     [Google Scholar]
  21. McKendall R. R., Klassen T., Baringer J. R. 1979; Host defenses in herpes simplex infections of the nervous system : effect of antibody on disease and viral spread. Infection and Immunity 23:305–311
     [Google Scholar]
  22. Metcalf J. F., Koga J., Chatterjee S., Whitley R. J. 1987; Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Current Eye Research 6:173–177
     [Google Scholar]
  23. Nash A. A., Field H. J., Quartey-Papafio R. 1980; Cell-mediated immunity in herpes simplex virus-infected mice : induction, characterization and antiviral effects of delayed type hypersensitivity. Journal of General Virology 48:351–357
     [Google Scholar]
  24. Nash A. A., Jayasuriya A., Phelan J., Cobbold S. P., Waldmann H., Prospero T. 1987; Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68:825–833
     [Google Scholar]
  25. Oakes J. E., Rosemond-Hornbeak H. 1978; Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infection and Immunity 21:489–495
     [Google Scholar]
  26. Reed J. L., Muench A. 1938; A simple method for estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
     [Google Scholar]
  27. Schneweis K. E., Forstbauer H., Olbrich M., , & Tag M. 1984; Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains. Medical Microbiology and Immunology 173:187–196
     [Google Scholar]
  28. Schneweis K. E., Brado M., Ebers B., Friedrich A., Olbrich M., , & Schuler W. 1988; Immunological mechanisms giving rise to latency of herpes simplex virus in the spinal ganglia of the mouse. Medical Microbiology and Immunology 177:1–8
     [Google Scholar]
  29. Sekizawa T., Openshaw H., Wohlenberg C., Notkins A. L. 1980; Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation. Science 210:1026–1028
     [Google Scholar]
  30. Sethi K. K. 1983; Effects of monoclonal antibodies directed against herpes simplex virus-specified glycoproteins on the generation of virus-specific and H-2-restricted cytotoxic T-lymphocytes. Journal of General Virology 64:2033–2037
     [Google Scholar]
  31. Shimeld C., Hill T. J., Blyth W. A., Easty D. L. 1990; Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. Journal of General Virology 71:681–687
     [Google Scholar]
  32. Sienko S., Eis-Hübinger A. M., Schneweis K. E. 1991; The role of free radical scavengers, inhibitors of prostaglandin synthesis, and hypomethylating agents in reactivation of latent herpes simplex virus. Medical Microbiology and Immunology 180:249–259
     [Google Scholar]
  33. Simmons A., Nash A. A. 1985; Role of antibody in primary and recurrent herpes simplex virus infection. Journal of Virology 53:944–948
     [Google Scholar]
  34. Simmons A., Nash A. A. 1987; Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. Journal of Infectious Diseases 155:649–654
     [Google Scholar]
  35. Staats H. F., Oakes J. E., Lausch R. N. 1991; Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. Journal of Virology 65:6008–6014
     [Google Scholar]
  36. Tullo A. B., Shimeld C., Blyth W. A., Hill T. J., Easty D. L. 1982a; Ocular infection with herpes simplex virus in nonimmune and immune mice. Archives of Ophthalmology 101:961–964
     [Google Scholar]
  37. Tullo A. B., Shimeld C., Blyth W. A., Hill T. J., Easty D. L. 1982b; Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. Journal of General Virology 63:95–101
     [Google Scholar]
  38. Whitby A. J., Blyth W. A., Hill T. J. 1987; The effect of DNA hypomethylating agents on the reactivation of herpes simplex virus from latently infected mouse ganglia in vitro. Archives of Virology 97:137–144
     [Google Scholar]
  39. Worthington M., Conliffe M. A., Baron S. 1980; Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. Journal of Infectious Diseases 142:163–174
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-3-379
Loading
Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes
J. Gen. Virol. 74, 379 (1993); https://doi.org/10.1099/0022-1317-74-3-379
/content/journal/jgv/10.1099/0022-1317-74-3-379
/content/journal/jgv/10.1099/0022-1317-74-3-379
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error